Search
for
Sort by
Research 121–150 of 294
- Redefining the “crown”: Approaching chemotherapy‐induced alopecia among Black patients with breast cancer
- The effect and mechanism of YH0618 granule on chemotherapy- induced hair loss in patients with breast cancer: study protocol for a randomized, double-blind, multi-center clinical trial
- The Impact of Chemotherapy on the Nutritional Status of Breast Cancer Patients
- Low-Dose Oral Minoxidil During Chemotherapy: A Review of the Mechanism and Current Evidence
- Scalp hypothermia as a preventative measure for chemotherapy‐induced alopecia: a review of controlled clinical trials
- Mild oxidative stress protects against chemotherapy-induced hair loss
- Cytoprotective role of human dental pulp stem cell-conditioned medium in chemotherapy-induced alopecia
- Drug-Loaded Extracellular Vesicle-Based Drug Delivery: Advances, Loading Strategies, Therapeutic Applications, and Clinical Challenges
- Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician’s Choice Standard-of-Care Chemotherapy
- Epigallocatechin-3-gallate inhibits paclitaxel-induced apoptosis through the alteration of microRNA expression in human dermal papilla cells
- Cancer-Related Alopecia: From Etiologies to Global Management
- 549 Temporary cell cycle arrest in human scalp hair follicles and their epithelial stem cells by ALRN-6924: A novel strategy to selectively protect p53-wildtype cells against paclitaxel-induced alopecia
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Dermatologic Adverse Events from Cancer Treatments
- Optimizing Scalp Cooling: (Ultra)Structural Follicular Characteristic and Restorative Advances
- Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022
- Hair and Nail Manifestations of Systemic Disease
- Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Safety First: A Comprehensive Review of Nutritional Supplements for Hair Loss in Breast Cancer Patients
- Resfriamento de couro cabeludo para prevenção de alopecia induzida por quimioterapia: Estudo descritivo
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Telomere Dynamics and Telomerase in the Biology of Hair Follicles and their Stem Cells as a Model for Aging Research
- Quality of Life in Slovak Breast Cancer Survivors: A Cross-Sectional Study Using EORTC QLQ-C30 and BR23
- Cutaneous Neuroimmune Interactions in Peripheral Neuropathic Pain States
- Management of Dermatologic Toxicities
- Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective
- Aromatase inhibitor therapy and hair loss among breast cancer survivors
- Minoxidil is a potential neuroprotective drug for paclitaxel-induced peripheral neuropathy
- Quality of Life of Patients with Metastatic Breast Cancer Treated with Epirubicin and Docetaxel